These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

261 related items for PubMed ID: 14526400

  • 1. Outcomes of hepatitis C- and hepatitis B core antibody-positive grafts in orthotopic liver transplantation.
    Saab S, Chang AJ, Comulada S, Geevarghese SK, Anselmo RD, Durazo F, Han S, Farmer DG, Yersiz H, Goldstein LI, Ghobrial RM, Busuttil RW.
    Liver Transpl; 2003 Oct; 9(10):1053-61. PubMed ID: 14526400
    [Abstract] [Full Text] [Related]

  • 2. Use of hepatitis B core antibody-positive liver allograft in hepatitis C virus-positive and -negative recipients with use of short course of hepatitis B immunoglobulin and Lamivudine.
    Jain A, Orloff M, Abt P, Kashyap R, Mohanka R, Lansing K, Kelley M, Bozorgzadeh A.
    Transplant Proc; 2005 Sep; 37(7):3187-9. PubMed ID: 16213345
    [Abstract] [Full Text] [Related]

  • 3. Risk of de novo hepatitis in liver recipients from hepatitis-B core antibody-positive grafts - a systematic analysis.
    Skagen CL, Jou JH, Said A.
    Clin Transplant; 2011 Sep; 25(3):E243-9. PubMed ID: 21323735
    [Abstract] [Full Text] [Related]

  • 4. Donor pool expansion in liver transplantation.
    Montalti R, Nardo B, Bertelli R, Beltempo P, Puviani L, Vivarelli M, Cavallari A.
    Transplant Proc; 2004 Apr; 36(3):520-2. PubMed ID: 15110578
    [Abstract] [Full Text] [Related]

  • 5. Outcomes of liver transplantation in simultaneously hepatitis B surface antigen and hepatitis C virus RNA positive recipients: the deleterious effect of donor hepatitis B core antibody positivity.
    Tandoi F, Romagnoli R, Martini S, Mazza E, Nada E, Cocchis D, Lupo F, Salizzoni M.
    Transplant Proc; 2012 Sep; 44(7):1960-2. PubMed ID: 22974882
    [Abstract] [Full Text] [Related]

  • 6. Lamivudine monoprophylaxis for de novo HBV infection in HBsAg-negative recipients with HBcAb-positive liver grafts.
    Vizzini G, Gruttadauria S, Volpes R, D'Antoni A, Pietrosi G, Filì D, Petridis I, Pagano D, Tuzzolino F, Santonocito MM, Gridelli B.
    Clin Transplant; 2011 Sep; 25(1):E77-81. PubMed ID: 21039887
    [Abstract] [Full Text] [Related]

  • 7. Lamivudine prophylaxis of liver allograft HBV reinfection in HBV related cirrhotic patients after liver transplantation.
    Lu SC, Yan LN, Li B, Wen TF, Zhao JC, Cheng NS, Liu C, Liu J, Wang XB, Li XD, Qin S, Zhao LS, Lei BJ, Zhang XH.
    Hepatobiliary Pancreat Dis Int; 2004 Feb; 3(1):26-32. PubMed ID: 14969833
    [Abstract] [Full Text] [Related]

  • 8. Safe use of livers from donors with positive hepatitis B core antibody.
    Manzarbeitia C, Reich DJ, Ortiz JA, Rothstein KD, Araya VR, Munoz SJ.
    Liver Transpl; 2002 Jun; 8(6):556-61. PubMed ID: 12037788
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Impact of donor age on survival and fibrosis progression in patients with hepatitis C undergoing liver transplantation using HCV+ allografts.
    Khapra AP, Agarwal K, Fiel MI, Kontorinis N, Hossain S, Emre S, Schiano TD.
    Liver Transpl; 2006 Oct; 12(10):1496-503. PubMed ID: 16964597
    [Abstract] [Full Text] [Related]

  • 12. Kidney transplantation from hepatitis B virus core antibody-positive donors: prophylaxis with hepatitis B immunoglobulin.
    Veroux M, Corona D, Ekser B, Giaquinta A, Tallarita T, De Martino C, Gentile F, Virgilio C, Gagliano M, Fiamingo P, Veroux P.
    Transplant Proc; 2011 May; 43(4):967-70. PubMed ID: 21620027
    [Abstract] [Full Text] [Related]

  • 13. Liver transplantation using young pediatric donor grafts in adults with hepatitis C infection.
    Ghabril M, Dickson RC, Krishna M, Bonatti H, Aranda-Michel J, Keaveny AP, Satyanarayana R, Hewitt W, Hughes CB, Nguyen JH.
    Transplantation; 2009 Apr 27; 87(8):1174-9. PubMed ID: 19384164
    [Abstract] [Full Text] [Related]

  • 14. Safety of hepatitis B virus core antibody-positive grafts in liver transplantation: A single-center experience in China.
    Lei M, Yan LN, Yang JY, Wen TF, Li B, Wang WT, Wu H, Xu MQ, Chen ZY, Wei YG.
    World J Gastroenterol; 2018 Dec 28; 24(48):5525-5536. PubMed ID: 30622380
    [Abstract] [Full Text] [Related]

  • 15. Hepatitis B-core antibody positive donors in liver transplantation and their impact on graft survival: evidence from the Liver Match cohort study.
    Angelico M, Nardi A, Marianelli T, Caccamo L, Romagnoli R, Tisone G, Pinna AD, Avolio AW, Fagiuoli S, Burra P, Strazzabosco M, Costa AN, Liver Match Investigators.
    J Hepatol; 2013 Apr 28; 58(4):715-23. PubMed ID: 23201239
    [Abstract] [Full Text] [Related]

  • 16. Hepatitis C virus recurrence after liver transplantation: relationship to anti-HCV core IgM, genotype, and level of viremia.
    Crespo J, Carte B, Lozano JL, Casafont F, Rivero M, de la Cruz F, Pons-Romero F.
    Am J Gastroenterol; 1997 Sep 28; 92(9):1458-62. PubMed ID: 9317062
    [Abstract] [Full Text] [Related]

  • 17. Predictors of patient and graft survival following liver transplantation for hepatitis C.
    Charlton M, Seaberg E, Wiesner R, Everhart J, Zetterman R, Lake J, Detre K, Hoofnagle J.
    Hepatology; 1998 Sep 28; 28(3):823-30. PubMed ID: 9731579
    [Abstract] [Full Text] [Related]

  • 18. Survival after orthotopic liver transplantation: the impact of antibody against hepatitis B core antigen in the donor.
    Yu L, Koepsell T, Manhart L, Ioannou G.
    Liver Transpl; 2009 Oct 28; 15(10):1343-50. PubMed ID: 19790164
    [Abstract] [Full Text] [Related]

  • 19. Donor age affects fibrosis progression and graft survival after liver transplantation for hepatitis C.
    Machicao VI, Bonatti H, Krishna M, Aqel BA, Lukens FJ, Nguyen JH, Rosser BG, Satyanarayana R, Grewal HP, Hewitt WR, Harnois DM, Crook JE, Steers JL, Dickson RC.
    Transplantation; 2004 Jan 15; 77(1):84-92. PubMed ID: 14724440
    [Abstract] [Full Text] [Related]

  • 20. Use of liver grafts from donation after cardiac death donors for recipients with hepatitis C virus.
    Taner CB, Bulatao IG, Keaveny AP, Willingham DL, Pungpapong S, Perry DK, Rosser BG, Harnois DM, Aranda-Michel J, Nguyen JH.
    Liver Transpl; 2011 Jun 15; 17(6):641-9. PubMed ID: 21618684
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.